AO
Algul, Oztekin
27 papers · 396 citations · 2021–2025
Publications
27
Citations
396
Years
5
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Substituted bisbenzimidazole derivatives as multiple targeting agents to treat Alzheimer's disease, diabetes, and microbial infections
|
2025 | Article | 5 |
|
Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and <i>in silico</i> studies
|
2025 | Review | 34 |
|
Design, Synthesis, and In Silico Analyses of Nitroimidazole Derivatives Targeting Cholinesterases
|
2025 | Article | 3 |
|
Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1/VEGFR2-mediated angiogenesis
|
2025 | Article | 2 |
|
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells
|
2025 | Article | 5 |
|
Deep learning approach to the discovery of novel bisbenzazole derivatives for antimicrobial effect
|
2024 | Article | 10 |
|
Assessing the Antiangiogenic Effects of Chalcones and Their Derivatives
|
2024 | Article | 7 |
|
Investigation of Some Metabolic Enzyme Inhibition Properties of Novel Chalcone-Cu Complexes
|
2024 | Article | 5 |
|
Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents
|
2023 | Article | 19 |
|
New Fluoro- and Trifluoromethyl-Substituted Trimethoxychalcones as Anticancer Agents: Synthesis, Bio-evaluation, and Computational Studies
|
2023 | Article | 3 |
|
N-(benzazol-2-yl)-2-substituted phenylacetamide derivatives: Design, synthesis and biological evaluation against MCF7 breast cancer cell line
|
2023 | Article | 4 |
|
Synthesis, <i>In Vitro</i> Biological Evaluation, and Molecular Docking Studies of Novel Biphenyl Chalcone Derivatives as Antimicrobial Agents
|
2022 | Article | 3 |
|
Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies
|
2022 | Article | 32 |
|
Design, synthesis and <i>in vitro</i> antiproliferation activity of some 2-aryl and -heteroaryl benzoxazole derivatives
|
2022 | Article | 19 |
|
2-Phenyl substituted Benzimidazole derivatives: Design, synthesis, and evaluation of their antiproliferative and antimicrobial activities
|
2022 | Article | 11 |
|
Synthesis, molecular docking and some metabolic enzyme inhibition properties of biphenyl-substituted chalcone derivatives
|
2022 | Article | 35 |
|
Synthesis, Biological Evaluation and <i>In Silico</i> Studies of Some 2-Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer
|
2022 | Article | 24 |
|
Bisbenzoxazole Derivatives: Design, Synthesis, <i>in Vitro</i> Antimicrobial, Antiproliferative Activity, and Molecular Docking Studies
|
2022 | Article | 9 |
|
Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives
|
2022 | Article | 8 |
|
New chalcone derivatives as effective against SARS-CoV-2 agent
|
2021 | Article | 29 |
|
Synthesis and biological evaluation of 3,5-diaryl-pyrazole derivatives as potential antiprostate cancer agents
|
2021 | Article | 5 |
|
Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents
|
2021 | Article | 17 |
|
Bisbenzimidazole Derivatives as Potential Antimicrobial Agents: Design, Synthesis, Biological Evaluation and Pharmacophore Analysis
|
2021 | Article | 11 |
|
One-pot synthesis of novel benzimidazoles with a naphthalene moiety as antimicrobial agents and molecular docking studies
|
2021 | Article | 15 |
|
An efficient synthesis of novel di-heterocyclic benzazole derivatives and evaluation of their antiproliferative activities
|
2021 | Article | 21 |
|
Head-to-head bisbenzazole derivatives as antiproliferative agents: design, synthesis, in vitro activity, and SAR analysis
|
2021 | Article | 17 |
|
Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes
|
2021 | Article | 43 |